XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Class A Common Stock [Member]
Common Stock [Member]
Class B Common Stock [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning balance at Dec. 31, 2020 $ 378,586   $ 4 $ 3 $ 474,669   $ (93,293)   $ (2,797)
Beginning balance (in shares) at Dec. 31, 2020     44,216 30,111          
Net income (loss) 14,360           14,360    
Exercise of stock options 271       271        
Exercise of stock options (in shares)     490            
Vesting of restricted stock (in shares)     278            
Conversion from Class B to Class A common stock     510 (510)          
Stock-based compensation 9,644       9,644        
Foreign currency translation, net of tax (3,975)               (3,975)
Retirement related benefit plans, net of tax 143               143
Ending balance at Mar. 31, 2021 399,029   $ 4 $ 3 484,584   (78,933)   (6,629)
Ending balance (in shares) at Mar. 31, 2021     45,494 29,601          
Beginning balance at Dec. 31, 2020 378,586   $ 4 $ 3 474,669   (93,293)   (2,797)
Beginning balance (in shares) at Dec. 31, 2020     44,216 30,111          
Net income (loss) (7,397)                
Repurchase and retirement of common stock 0                
Foreign currency translation, net of tax (5,685)                
Retirement related benefit plans, net of tax 344                
Ending balance at Sep. 30, 2021 602,262   $ 5 $ 3 711,082   (100,690)   (8,138)
Ending balance (in shares) at Sep. 30, 2021     50,558 28,206          
Beginning balance at Mar. 31, 2021 399,029   $ 4 $ 3 484,584   (78,933)   (6,629)
Beginning balance (in shares) at Mar. 31, 2021     45,494 29,601          
Net income (loss) (13,648)           (13,648)    
Exercise of stock options 614       614        
Exercise of stock options (in shares)     334            
Vesting of restricted stock (in shares)     54            
Conversion from Class B to Class A common stock     510 (510)          
Stock-based compensation 10,626       10,626        
Foreign currency translation, net of tax 2,640               2,640
Retirement related benefit plans, net of tax 84               84
Ending balance at Jun. 30, 2021 399,345   $ 4 $ 3 495,824   (92,581)   (3,905)
Ending balance (in shares) at Jun. 30, 2021     46,392 29,091          
Net income (loss) (8,109)           (8,109)    
Issuance of common stock in private placement, net of issuance costs 199,872   $ 1   199,871        
Issuance of common stock in private placement, net of issuance costs (in shares)     2,936            
Issuance of common stock for acquisitions 3,280       3,280        
Issuance of common stock for acquisitions (in shares)     53            
Exercise of stock options 1,174       1,174        
Exercise of stock options (in shares)     264            
Vesting of restricted stock (in shares)     28            
Conversion from Class B to Class A common stock     885 (885)          
Stock-based compensation 10,933       10,933        
Foreign currency translation, net of tax (4,350)               (4,350)
Retirement related benefit plans, net of tax 117               117
Ending balance at Sep. 30, 2021 602,262   $ 5 $ 3 711,082   (100,690)   (8,138)
Ending balance (in shares) at Sep. 30, 2021     50,558 28,206          
Beginning balance at Dec. 31, 2021 613,197 $ (26,070) $ 5 $ 3 724,226 $ (50,009) (102,087) $ 23,939 (8,950)
Beginning balance (in shares) at Dec. 31, 2021     51,524 27,745          
Net income (loss) 11,528           11,528    
Issuance of common stock for employee stock purchase program 4,187       4,187        
Issuance of common stock for employee stock purchase program (in shares)     77            
Exercise of stock options 238       238        
Exercise of stock options (in shares)     86            
Vesting of restricted stock (in shares)     324            
Stock-based compensation 19,403       19,403        
Foreign currency translation, net of tax (4,163)               (4,163)
Retirement related benefit plans, net of tax 105               105
Ending balance at Mar. 31, 2022 618,425   $ 5 $ 3 698,045   (66,620)   (13,008)
Ending balance (in shares) at Mar. 31, 2022     52,011 27,745          
Beginning balance at Dec. 31, 2021 613,197 $ (26,070) $ 5 $ 3 724,226 $ (50,009) (102,087) $ 23,939 (8,950)
Beginning balance (in shares) at Dec. 31, 2021     51,524 27,745          
Net income (loss) (55,494)                
Repurchase and retirement of common stock (4,387)                
Foreign currency translation, net of tax (37,929)                
Retirement related benefit plans, net of tax 306                
Ending balance at Sep. 30, 2022 535,529   $ 5 $ 3 715,736   (133,642)   (46,573)
Ending balance (in shares) at Sep. 30, 2022     52,377 27,745          
Beginning balance at Mar. 31, 2022 618,425   $ 5 $ 3 698,045   (66,620)   (13,008)
Beginning balance (in shares) at Mar. 31, 2022     52,011 27,745          
Net income (loss) (33,774)           (33,774)    
Settlement of convertible senior notes (29,756)       (29,756)        
Repurchase and retirement of common stock (4,387)       (4,387)        
Payments for repurchase of common stock, Shares     (85)            
Reclassification of mezzanine equity to permanent equity 784       784        
Exercise of stock options 1,452       1,452        
Exercise of stock options (in shares)     222            
Vesting of restricted stock (in shares)     43            
Stock-based compensation 21,200       21,200        
Foreign currency translation, net of tax (15,949)               (15,949)
Retirement related benefit plans, net of tax 177               177
Ending balance at Jun. 30, 2022 558,172   $ 5 $ 3 687,338   (100,394)   (28,780)
Ending balance (in shares) at Jun. 30, 2022     52,191 27,745          
Net income (loss) (33,248)           (33,248)    
Issuance of common stock for employee stock purchase program 4,536       4,536        
Issuance of common stock for employee stock purchase program (in shares)     108            
Exercise of stock options 1,152       1,152        
Exercise of stock options (in shares)     56            
Vesting of restricted stock (in shares)     22            
Stock-based compensation 22,710       22,710        
Foreign currency translation, net of tax (17,817)               (17,817)
Retirement related benefit plans, net of tax 24               24
Ending balance at Sep. 30, 2022 $ 535,529   $ 5 $ 3 $ 715,736   $ (133,642)   $ (46,573)
Ending balance (in shares) at Sep. 30, 2022     52,377 27,745